Xavier Ferry

As Chief Financial Officer and member of executive board director of Graftys, Xavier is responsible for the group’s global finances, investor relations and controllership.

He joined the Graftys team in Nov 2021 after spending 2.5 years as CFO at Biologics 4 life, where he played a major role in the M&A operation with Graftys.

Xavier brings fifteen years of experience as CFO and a seasoned investor in Medtech startups (in which he successfully sold 20 companies).

He holds a phD in Pharmacology and a Master of Science in Management.